A Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse.
Phase of Trial: Phase IV
Latest Information Update: 07 Sep 2012
At a glance
- Drugs Paliperidone; Risperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceuticals
- 03 Aug 2012 Actual end date (5 Feb 2010) added as reported by European Clinical Trials Database.
- 01 Aug 2012 Company added in association field as reported by European Clinical Trials Database.
- 13 Jul 2012 Trial phase changed from III to IV as reported by ClinicalTrials.gov.